NAN-190

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by JCW-CleanerBot (talk | contribs) at 19:54, 31 March 2018 (→‎top: task, replaced: journal = Neuroreport. → journal = NeuroReport using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

NAN-190
Skeletal formula of NAN-190
Space-filling model of the NAN-190 molecule
Identifiers
  • 1-(2-Methoxyphenyl)-4-(4-phthalimidobutyl)piperazine
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H27N3O3
Molar mass393.478 g/mol g·mol−1
3D model (JSmol)
  • O=C1c2ccccc2C(=O)N1CCCCN4CCN(CC4)c3ccccc3OC
  • InChI=1S/C23H27N3O3/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28/h2-5,8-11H,6-7,12-17H2,1H3 ☒N
  • Key:SJDOMIRMMUGQQK-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

NAN-190 is a drug and research chemical widely used in scientific studies. It was previously believed to act as a selective 5-HT1A receptor antagonist, but a subsequent discovery showed that it also potently blocks the α2-adrenergic receptor.[1] The new finding has raised significant concerns about studies using NAN-190 as a specific serotonin receptor antagonist.[1]

References

  1. ^ a b Foong JP, Bornstein JC (2009). "5-HT antagonists NAN-190 and SB 269970 block alpha2-adrenoceptors in the guinea pig". NeuroReport. 20 (3): 325–330. doi:10.1097/WNR.0b013e3283232caa. PMID 19190523.